Sclerostin and bone formation. osteoblasts, osteocytes, and osteoclasts

  • Preview image in your
    Facebook Timeline Account

  • Preview

  • Price: 1$
  • Size Facebook: 1702 x 630 px
  • Size Twitter: 1500 x 500 px
  • Size LinkedIn: 1128 x 191 px

More Facebook, Twitter and LinkedIn Cover Photos

More

Cover photo info

  • Photo title: Sclerostin and bone formation. osteoblasts, osteocytes, and osteoclasts
  • Author: Designua
  • Cover photo description:
  • Sclerostin is secreted by osteocytes and inhibits bone formation. treating osteoporosis and fracture. Paracrine actions of osteoblasts, osteocytes, and osteoclasts
  • Image ID:197974220
  • Views:0
  • Downloads:0

Keywords for Facebook, Twitter and LinkedIn timeline photos

amino anatomy biology body bone calcification calcitonin care cell diagram disease formation fracture gene glucocorticoids health hormone human illustration inhibits lining medical medicine molecule osteoblast osteoclast osteoclasts osteocyte osteoporosis paracrine parathormone parathyrin parathyroid pathway physiological pth regulator resorption science sclerosteosis sclerostin secreted section skeleton sost steroids structure tissue treating vector

Similar images from Dreamstime

Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a Rheumatoid arthritis Murine sclerostin: target for osteoporosis treatment
 
x